Since returning to the White House, President Trump has signed a series of executive orders reshaping federally funded ...
AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback